Testing effectiveness (Phase 2)Study completedNCT00256711What this trial is testingPhase II Iressa Versus Vinorelbine (INVITE)Who this might be right forNon-Small-Cell Lung Carcinoma AstraZeneca 192
Testing effectiveness (Phase 2)UnknownNCT04094909What this trial is testingRh-endostatin Combined With Chemotherapy and Pembrolizumab for Advanced NSCLCWho this might be right forStaging IV NSCLC Guangzhou Institute of Respiratory Disease 186
Testing effectiveness (Phase 2)Looking for participantsNCT07148128What this trial is testingPhase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.Who this might be right forAdvanced or Metastatic KRAS-mutant Tumor in Pancreatic AdenocarcinomaAdvanced or Metastatic KRAS-mutant Tumor in Colorectal CancerAdvanced or Metastatic KRAS-mutant Tumor in Non Small Cell Lung Cancer+2 more Auricula Biosciences Inc.
Testing effectiveness (Phase 2)Ended earlyNCT05091528What this trial is testingA Safety and Activity Study of SBT6050 in Combination With Other HER2-directed Therapies for HER2-positive CancersWho this might be right forHER2-positive Breast CancerHER2-positive Gastric CancerHER2-positive Colorectal Cancer+1 more Silverback Therapeutics 2
Early research (Phase 1)Ended earlyNCT06580938What this trial is testingLearn About PF-07921585 Alone or With Other Anti-cancer Medicines in People With CancerWho this might be right forNon Small Cell Lung CancerBladder CancerRenal Cell Carcinoma+3 more Pfizer 4
Testing effectiveness (Phase 2)UnknownNCT05507606What this trial is testingStudy of Osimertinib+Bevacizumab+Chemotherapy for EGFR+ Advanced Non-Small Cell Lung Cancer With Concurrent MutationsWho this might be right forNon Small Cell Lung Cancer Tianjin Medical University Cancer Institute and Hospital 50
Testing effectiveness (Phase 2)UnknownNCT05207904What this trial is testingTislelizumab Plus Chemotherapy as First-Line Treatment for Advanced Squamous NSCLC With Brain MetastasesWho this might be right forNon-Small Cell Squamous Lung CancerBrain Metastases Sun Yat-sen University 41
Early research (Phase 1)Study completedNCT02163733What this trial is testingStudy to Determine the Effect of Food on the Blood Levels of AZD9291 Following Oral Dosing of a Tablet Formulation in Patients With Non-Small Cell Lung CancerWho this might be right forAdvanced Non Small Cell Lung CancerAdvanced (Inoperable) Non Small Cell Lung Cancer AstraZeneca 38
Early research (Phase 1)Study completedNCT02009449What this trial is testingPegilodecakin (LY3500518) in Participants With Advanced Solid TumorsWho this might be right forMelanomaProstate CancerOvarian Cancer+6 more Eli Lilly and Company 353
Early research (Phase 1)Ended earlyNCT04244552What this trial is testingA Phase 1b Trial of ATRC-101 in Adults With Advanced Solid MalignanciesWho this might be right forBreast CancerColorectal CancerOvarian Cancer+13 more Atreca, Inc. 87
Early research (Phase 1)Study completedNCT00974584What this trial is testingThe Safety and Pharmacology Of PI3-Kinase Inhibitor GDC-0941 In Combination With Either Paclitaxel And Carboplatin (With or Without Bevacizumab) or Pemetrexed, Cisplatin, And Bevacizumab in Patients With Advanced Non-Small Cell Lung CancerWho this might be right forNon-Squamous Non-Small Cell Lung Cancer Genentech, Inc. 65
Not applicableStudy completedNCT05154344What this trial is testingRW Effectiveness of Capmatinib in Advanced MET-dysregulated NSCLC Included in the French Compassionate Use Program (ATU)Who this might be right forMET AlterationsNon Small Cell Lung CancerMETex14 Mutations Intergroupe Francophone de Cancerologie Thoracique 182
Testing effectiveness (Phase 2)Study completedNCT04311034What this trial is testingRC48-ADC in Subjects With Advanced Non-small Cell Lung CancerWho this might be right forNon Small Cell Lung Cancer RemeGen Co., Ltd. 37
Testing effectiveness (Phase 2)UnknownNCT05013099What this trial is testingStudy of Zirconium Zr 89 Crefmirlimab Berdoxam PET/CT in Subjects With Advanced or Metastatic MalignanciesWho this might be right forMelanomaMerkel Cell Carcinoma, UnspecifiedRenal Cell Carcinoma+1 more ImaginAb, Inc. 70
Testing effectiveness (Phase 2)Ended earlyNCT00420732What this trial is testingVaccine Maintenance Treatment for Non-Small Cell Lung CancerWho this might be right forCarcinoma, Non-Small-Cell Lung NewLink Genetics Corporation 6
Not applicableStudy completedNCT03170284What this trial is testingObservational Study to Evalute the Efficacy and Safety of Avastin (Bevacizumab) in Addition to Platinum-Based Chemotherapy for First-Line Treatment of Participants With Non-Small Cell Lung CancerWho this might be right forCarcinoma, Non-Small-Cell Lung Hoffmann-La Roche 150
Large-scale testing (Phase 3)Looking for participantsNCT06357533What this trial is testingPhase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic AlterationsWho this might be right forNon-Small Cell Lung Cancer AstraZeneca 675
Not applicableStudy completedNCT05419700What this trial is testingA Spanish Medical Record Review of Clinical Characteristics and Outcomes in Non-small Cell Lung Cancer Participants With EGFR Exon 20 InsertionWho this might be right forNon-small Cell Lung Cancer (NSCLC) Takeda 76
Testing effectiveness (Phase 2)Ended earlyNCT02115464What this trial is testingAdvanced Lung Cancer Treatment With Metformin and Chemo-RadiotherapyWho this might be right forLung Cancer Ontario Clinical Oncology Group (OCOG) 54
Testing effectiveness (Phase 2)Ended earlyNCT01526928What this trial is testingStudy to Evaluate Safety, Pharmacokinetics, and Efficacy of Rociletinib (CO-1686) in Previously Treated Mutant Epidermal Growth Factor Receptor (EGFR) in Non-Small Cell Lung Cancer (NSCLC) PatientsWho this might be right forLocally Advanced or Metastatic Non Small Cell Lung Cancer Clovis Oncology, Inc. 612